Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
for IC-MPGN
22 locations incl. Los Angeles
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 12 - 60
Code: NCT05755386·Phase 3·Recruiting·Listed Mar 2023
MUSC Health Lancaster Med Ctr
Clinical research site in Lancaster, South Carolina
Part of Medical University of South Carolina
As of July 2026, 1 paid clinical trial is recruiting at MUSC Health Lancaster Med Ctr in Lancaster, South Carolina. Active studies at this site focus on IC-MPGN alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at MUSC Health Lancaster Med Ctr (1)
More research sites in Lancaster
- Lancaster Radiation Therapy Center (2 trials)
- MD First Research - Lancaster (1 trial)
- MUSC Health Lancaster Medical Center (1 trial)
- MUSC Lancaster (1 trial)
- MUSC Mid-Carolinas Transplant Center (1 trial)
Explore more
Paid clinical trials in Lancaster, SC · South Carolina clinical trials